This Coinbase Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - EHang Holdings (NASDAQ:EH), Coinbase Global (NASDAQ:COIN)
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. D. Boral Capital analyst Jason Kolbert downgraded the rating for Invivyd Inc ( NASDAQ:IVVD ) ...

Despite a recent analyst downgrade, Coinbase (COIN) maintains a bullish sentiment with positive technical indicators, suggesting potential for short-term gains.
High relevance due to bullish sentiment and recent analyst downgrade of competitors.
Moderate upward movement (~3-5%) over the next 2 weeks.
Background
Recent analyst downgrades in the financial sector, especially for stocks like Invivyd Inc, have caused sector-wide caution.
Why it matters
While some stocks are downgraded, Coinbase remains bullish, indicating sector divergence and potential for selective trading.
Market relevance
The news highlights sector-specific analyst sentiment shifts, with particular focus on Coinbase's bullish outlook amid sector downgrades.
Market effects
Potential sector rotation; investors may shift from downgraded stocks to more bullish ones like COIN.
Limited; primarily U.S.-based stocks affected.
Moderate; cryptocurrency sector may see increased interest due to COIN's outlook.
Alternative perspectives
The analyst downgrade could signal broader sector weakness, suggesting caution in bullish positions.
Potential regulatory developments or macroeconomic factors that could impact cryptocurrency prices and related stocks.
Key entities
- CompanyCoinbase Global (COIN)
A leading cryptocurrency exchange with a bullish sentiment despite sector downgrades.
- CompanyInvivyd Inc (IVVD)
A biotech firm affected by recent analyst downgrades.
- CompanyEHang Holdings (EH)
An autonomous aerial vehicle manufacturer with neutral analyst sentiment.
- CompanyCameo Cares Inc (CCORF)
A company in the entertainment sector, unaffected by recent analyst activity.
- CompanyExact Sciences Corp (EXAS)
A biotech firm with neutral outlook.

